You can buy or sell Opthea and other stocks, options, and ETFs commission-free!
Opthea Limited American Depositary Shares, also called Opthea, is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia. The listed name for OPT is Opthea Limited American Depositary Shares.
South Yarra, Victoria (VIC)
52 Week High
52 Week Low